×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
CVKD – cadrenal therapeutics, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
CVKD
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
1/12
08:00 am
cvkd
Cadrenal Therapeutics Highlights High Incidence of Thrombotic Complications in Heparin-Induced Thrombocytopenia (HIT) at the J.P. Morgan Healthcare Conference and VLX-1005 as a Potential Therapeutic Solution as the First and Only Selective 12-LOX Inhibito
Medium
Report
Cadrenal Therapeutics Highlights High Incidence of Thrombotic Complications in Heparin-Induced Thrombocytopenia (HIT) at the J.P. Morgan Healthcare Conference and VLX-1005 as a Potential Therapeutic Solution as the First and Only Selective 12-LOX Inhibito
12/30
07:07 pm
cvkd
Cadrenal's Pipeline Looks Less Like a Microcap and More Like an Emergency Response System [Yahoo! Finance]
Low
Report
Cadrenal's Pipeline Looks Less Like a Microcap and More Like an Emergency Response System [Yahoo! Finance]
12/29
08:12 am
cvkd
Cadrenal Is Rebuilding the Parts of Anticoagulation Everyone Else Gave Up On [Yahoo! Finance]
Medium
Report
Cadrenal Is Rebuilding the Parts of Anticoagulation Everyone Else Gave Up On [Yahoo! Finance]
12/17
09:00 am
cvkd
Cadrenal Therapeutics to Conduct Partnering and Investor Meetings During the J.P. Morgan 44th Annual Healthcare Conference in San Francisco on January 12-15, 2026
Medium
Report
Cadrenal Therapeutics to Conduct Partnering and Investor Meetings During the J.P. Morgan 44th Annual Healthcare Conference in San Francisco on January 12-15, 2026
12/11
08:27 am
cvkd
Cadrenal Therapeutics Acquires VLX-1005, a First-in-Class Phase 2 12-LOX Inhibitor for Patients with Heparin-Induced Thrombocytopenia (HIT) [Yahoo! Finance]
Medium
Report
Cadrenal Therapeutics Acquires VLX-1005, a First-in-Class Phase 2 12-LOX Inhibitor for Patients with Heparin-Induced Thrombocytopenia (HIT) [Yahoo! Finance]
12/11
08:05 am
cvkd
Cadrenal Therapeutics Acquires VLX-1005, a First-in-Class Phase 2 12-LOX Inhibitor for Patients with Heparin-Induced Thrombocytopenia (HIT)
Medium
Report
Cadrenal Therapeutics Acquires VLX-1005, a First-in-Class Phase 2 12-LOX Inhibitor for Patients with Heparin-Induced Thrombocytopenia (HIT)
12/1
09:00 am
cvkd
Cadrenal Therapeutics Appoints Dr. Lee Golden to Board of Directors
Low
Report
Cadrenal Therapeutics Appoints Dr. Lee Golden to Board of Directors
11/19
08:00 am
cvkd
Cadrenal Therapeutics CEO, Quang X. Pham, Receives BioFlorida’s Executive of the Year Award
Medium
Report
Cadrenal Therapeutics CEO, Quang X. Pham, Receives BioFlorida’s Executive of the Year Award
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
1/2
04:06 pm
cvkd
Form 424B3 Cadrenal Therapeutics,
Low
Report
Form 424B3 Cadrenal Therapeutics,
1/2
06:05 am
cvkd
Form EFFECT Cadrenal Therapeutics,
Medium
Report
Form EFFECT Cadrenal Therapeutics,
12/31
04:25 pm
cvkd
Form D Cadrenal Therapeutics,
Medium
Report
Form D Cadrenal Therapeutics,
12/31
04:05 pm
cvkd
Form 4 Cadrenal Therapeutics, For: Dec 29 Filed by: Szot Matthew K
Medium
Report
Form 4 Cadrenal Therapeutics, For: Dec 29 Filed by: Szot Matthew K
12/29
04:25 pm
cvkd
Form 144 Cadrenal Therapeutics, Filed by: Szot Matthew K
Medium
Report
Form 144 Cadrenal Therapeutics, Filed by: Szot Matthew K
12/29
06:02 am
cvkd
Form S-1 Cadrenal Therapeutics,
Medium
Report
Form S-1 Cadrenal Therapeutics,
12/23
04:59 pm
cvkd
Form 8-K Cadrenal Therapeutics, For: Dec 23
Medium
Report
Form 8-K Cadrenal Therapeutics, For: Dec 23
12/23
04:57 pm
cvkd
Form 424B5 Cadrenal Therapeutics,
Medium
Report
Form 424B5 Cadrenal Therapeutics,
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: